Dimethyllysergamide: Difference between revisions

Dimethyllysergamide
Clinical data
Other names	DAM-57, Lysergic acid dimethylamide
Routes of; administration	Oral
Legal status
Legal status	Controlled in the US via the Federal Analog Act but only if it is intended for human consumption.;
Pharmacokinetic data
Metabolism	hepatic
Excretion	renal
Identifiers
	IUPAC name (6aR,9R)-N,N-dimethyl-7-methyl-4,6,6a,7,8,9-; hexahydroindolo-[4,3-fg]quinoline-9-carboxamide;
PubChem CID	199478;
ChemSpider	172668 ;
CompTox Dashboard (EPA)	DTXSID30962445 ;
Chemical and physical data
Formula	C18H21N3O
Molar mass	295.39 g/mol g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O=C(N(C)C)[C@@H]3/C=C2/c4cccc1c4c(cn1)C[C@H]2N(C3)C;
	InChI InChI=1S/C18H21N3O/c1-20(2)18(22)12-7-14-13-5-4-6-15-17(13)11(9-19-15)8-16(14)21(3)10-12/h4-7,9,12,16,19H,8,10H2,1-3H3/t12-,16-/m1/s1 ; Key:FWHSERNVTGTIJE-MLGOLLRUSA-N ;
	(verify)

Content deleted Content added

Inline

Revision as of 02:39, 4 March 2011

N,N-Dimethyllysergamide (DAM-57) is a derivative of ergine.

It may cause LSD-like effects at doses of 1 milligram or more but this is disputed.

This hallucinogen-related article is a stub. You can help Wikipedia by expanding it.

@@ Line 24: / Line 24: @@
 | legal_UK =
 | legal_US =
-| legal_status = Controlled in the [[US]] via the [[Federal Analog Act]]
+| legal_status = Controlled in the [[US]] via the [[Federal Analog Act]] but only if it is intended for human consumption.
 | routes_of_administration = [[Wiktionary:oral|Oral]]}}